DeepMed Research

The Sidney Kimmel Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Employees: -

Market Cap: -

Website: http://www.hopkinsmedicine.org/kimmel_cancer_center

Clinical Trials

Freehand Ultrasound Elasticity Imaging in Liver Surgery

Terminated

Conditions: Liver Tumors

First Posted Date: 2009-07-20

Last Posted Date: 2019-03-28

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 15

Registration Number: NCT00942383

Locations: 🇺🇸
SKCCC, Baltimore, Maryland, United States

Studying Fentanyl in Patients With Cancer

Terminated

Conditions: Brain and Central Nervous System Tumors
Chronic Myeloproliferative Disorders
Leukemia
Lymphoma
Lymphoproliferative Disorder
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Neoplasms
Pain
Precancerous Condition

Interventions: Drug: fentanyl citrate
Other: pharmacological study

First Posted Date: 2009-05-12

Last Posted Date: 2013-04-18

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 2

Registration Number: NCT00899951

Locations: 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Tumor DNA and MRI/CT Scan Findings in Patients With Grade III or Grade IV Malignant Glioma

Not Applicable

Completed

Conditions: High Grade Glioma

First Posted Date: 2009-05-12

Last Posted Date: 2012-11-30

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 42

Registration Number: NCT00897611

Collecting and Storing Samples of Blood From Patients With Pancreatic Cancer and Healthy Participants

Completed

Conditions: Pancreatic Cancer

Interventions: Other: This is a non-intervention study for all groups.
Other: study of socioeconomic and demographic variables

First Posted Date: 2009-05-12

Last Posted Date: 2015-11-20

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 88

Registration Number: NCT00898482

Epidermal Growth Factor Receptor Mutations in the Blood of Patients With Advanced Non-Small Cell Lung Cancer

Completed

Conditions: Lung Cancer

First Posted Date: 2009-05-12

Last Posted Date: 2019-02-15

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 50

Registration Number: NCT00899756

Locations: 🇸🇬
Alex Chang, Singapore, Singapore

Oral HPV Infection in Young Men

Completed

Conditions: Head and Neck Cancer
Infection
Precancerous Condition

First Posted Date: 2009-05-12

Last Posted Date: 2019-01-17

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 500

Registration Number: NCT00897273

DNA in Predicting Response After Systemic Therapy in Women With Metastatic Breast Cancer

Completed

Conditions: Breast Cancer

Interventions: Genetic: DNA methylation analysis
Genetic: microarray analysis
Genetic: polymerase chain reaction
Other: laboratory biomarker analysis

First Posted Date: 2009-05-12

Last Posted Date: 2019-07-26

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 182

Registration Number: NCT00899548

Locations: 🇺🇸
Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States
🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States

and more 1 locations

Identifying Circulating Breast Cancer Cells in Women With Metastatic Breast Cancer

Completed

Conditions: Breast Cancer

First Posted Date: 2009-05-12

Last Posted Date: 2015-10-12

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 43

Registration Number: NCT00897338

Locations: 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme

Phase 2

Completed

Conditions: Adult Glioblastoma Multiforme

Interventions: Biological: olaratumab
Biological: ramucirumab

First Posted Date: 2009-05-08

Last Posted Date: 2017-12-27

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 80

Registration Number: NCT00895180

Locations: 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute at University of South Florida, Tampa, Florida, United States
🇺🇸
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
🇺🇸
University of California San Francisco Medical Center, San Francisco, California, United States

and more 8 locations

A Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract

Phase 2

Completed

Conditions: Head and Neck Squamous Cell Carcinoma

Interventions: Other: Placebo Pill
Drug: Tadalafil

First Posted Date: 2009-05-07

Last Posted Date: 2019-06-11

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 45

Registration Number: NCT00894413

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy